Author:
Publisher:
ISBN:
Category : Corporations
Languages : en
Pages : 1016
Book Description
Nelson's Directory of Investment Research
Sterile Drug Products
Author: Michael J. Akers
Publisher: CRC Press
ISBN: 1420020560
Category : Medical
Languages : en
Pages : 517
Book Description
Sterile Drug Products: Formulation, Packaging, Manufacturing, and Quality teaches the basic principles of the development and manufacture of high quality sterile dosage forms. The author has 38 years of experience in the development and manufacture of sterile dosage forms including solutions, suspensions, ophthalmics and freeze dried products. This
Publisher: CRC Press
ISBN: 1420020560
Category : Medical
Languages : en
Pages : 517
Book Description
Sterile Drug Products: Formulation, Packaging, Manufacturing, and Quality teaches the basic principles of the development and manufacture of high quality sterile dosage forms. The author has 38 years of experience in the development and manufacture of sterile dosage forms including solutions, suspensions, ophthalmics and freeze dried products. This
Merger Arbitrage
Author: Thomas Kirchner
Publisher: John Wiley & Sons
ISBN: 1118736664
Category : Business & Economics
Languages : en
Pages : 528
Book Description
Mitigate risk and increase returns with an alternative hedge fund strategy Merger Arbitrage: How to Profit from Event-Driven Arbitrage, Second Edition is the definitive guide to the ins and outs of the burgeoning merger arbitrage hedge fund strategy, with real-world examples that illustrate how mergers work and how to take advantage of them. Author Thomas Kirchner, founder of the Pennsylvania Avenue Event-Driven Fund, discusses the factors that drove him to invest solely in merger arbitrage and other event-driven strategies, and details the methods used to incorporate merger arbitrage into traditional investment strategies. And while there is always a risk that a deal will fall through, the book explains how minimal such risks really are when the potential upside is factored in. Early chapters of the book focus on the basics of the merger arbitrage strategy, including an examination of mergers and the incorporation of risk into the arbitrage decision. Following chapters detail deal structures, financing, and legal aspects to provide the type of in-depth knowledge required to execute an effective investment strategy. The updated second edition stresses new, increasingly relevant information like: Worldwide legal deal regimes UK takeover code UK takeover code global offspring Regulators around the world The book provides clear, concise guidance on critical considerations including leverage and options, shorting stocks, and legal recourse for inadequate merger consideration, allowing readers to feel confident about trying a new investment strategy. With simple benefits including diversification of risk and return streams, this alternative hedge fund strategy has a place in even the most traditional plan. Merger Arbitrage: How to Profit from Event-Driven Arbitrage, Second Edition provides the information that gives investors an edge in the merger arbitrage arena.
Publisher: John Wiley & Sons
ISBN: 1118736664
Category : Business & Economics
Languages : en
Pages : 528
Book Description
Mitigate risk and increase returns with an alternative hedge fund strategy Merger Arbitrage: How to Profit from Event-Driven Arbitrage, Second Edition is the definitive guide to the ins and outs of the burgeoning merger arbitrage hedge fund strategy, with real-world examples that illustrate how mergers work and how to take advantage of them. Author Thomas Kirchner, founder of the Pennsylvania Avenue Event-Driven Fund, discusses the factors that drove him to invest solely in merger arbitrage and other event-driven strategies, and details the methods used to incorporate merger arbitrage into traditional investment strategies. And while there is always a risk that a deal will fall through, the book explains how minimal such risks really are when the potential upside is factored in. Early chapters of the book focus on the basics of the merger arbitrage strategy, including an examination of mergers and the incorporation of risk into the arbitrage decision. Following chapters detail deal structures, financing, and legal aspects to provide the type of in-depth knowledge required to execute an effective investment strategy. The updated second edition stresses new, increasingly relevant information like: Worldwide legal deal regimes UK takeover code UK takeover code global offspring Regulators around the world The book provides clear, concise guidance on critical considerations including leverage and options, shorting stocks, and legal recourse for inadequate merger consideration, allowing readers to feel confident about trying a new investment strategy. With simple benefits including diversification of risk and return streams, this alternative hedge fund strategy has a place in even the most traditional plan. Merger Arbitrage: How to Profit from Event-Driven Arbitrage, Second Edition provides the information that gives investors an edge in the merger arbitrage arena.
Nelson Information's Directory of Investment Research
Martindale
Author: Sean C. Sweetman
Publisher:
ISBN: 9780853697046
Category : Medical
Languages : en
Pages : 3335
Book Description
This is thirty-fifth edition of Martindale, which provides reliable, and evaluated information on drugs and medicines used throughout the world. It contains encyclopaedic facts about drugs and medicines, with: 5,500 drug monographs; 128,000 preparations; 40,700 reference citations; 10,900 manufacturers. There are synopses of disease treatments which enables identification of medicines, the local equivalent and the manufacturer. It also Includes herbals, diagnostic agents, radiopharmaceuticals, pharmaceutical excipients, toxins, and poisons as well as drugs and medicines. Based on published information and extensively referenced
Publisher:
ISBN: 9780853697046
Category : Medical
Languages : en
Pages : 3335
Book Description
This is thirty-fifth edition of Martindale, which provides reliable, and evaluated information on drugs and medicines used throughout the world. It contains encyclopaedic facts about drugs and medicines, with: 5,500 drug monographs; 128,000 preparations; 40,700 reference citations; 10,900 manufacturers. There are synopses of disease treatments which enables identification of medicines, the local equivalent and the manufacturer. It also Includes herbals, diagnostic agents, radiopharmaceuticals, pharmaceutical excipients, toxins, and poisons as well as drugs and medicines. Based on published information and extensively referenced
Thomas Register of American Manufacturers and Thomas Register Catalog File
Author:
Publisher:
ISBN:
Category : Industrialists
Languages : en
Pages : 1918
Book Description
Vols. for 1970-71 includes manufacturers' catalogs.
Publisher:
ISBN:
Category : Industrialists
Languages : en
Pages : 1918
Book Description
Vols. for 1970-71 includes manufacturers' catalogs.
INVOKANA Drug Profile, 2023
Author: DrugPatentWatch
Publisher: DrugPatentWatch.com
ISBN: 1934899682
Category : Medical
Languages : en
Pages : 125
Book Description
Publisher: DrugPatentWatch.com
ISBN: 1934899682
Category : Medical
Languages : en
Pages : 125
Book Description
INVOKANA Drug Profile, 2023
This report focuses on INVOKANA and covers the following critical aspects of this drug:
- United States patents
- FDA Paragraph IV patent challenges
- District Court patent litigation
- European supplementary protection certificates (SPCs)
- Clinical trials
- Drug prices
- Annual sales revenues
- Finished product suppliers
- Raw active pharmaceutical ingredient (API) sources
SAVAYSA Drug Profile, 2023
Author: DrugPatentWatch
Publisher: DrugPatentWatch.com
ISBN: 1934899585
Category : Medical
Languages : en
Pages : 170
Book Description
Publisher: DrugPatentWatch.com
ISBN: 1934899585
Category : Medical
Languages : en
Pages : 170
Book Description
SAVAYSA Drug Profile, 2023
This report focuses on SAVAYSA and covers the following critical aspects of this drug:
- United States patents
- FDA Paragraph IV patent challenges
- European supplementary protection certificates (SPCs)
- Clinical trials
- Drug prices
- Finished product suppliers
- Raw active pharmaceutical ingredient (API) sources
TRUVADA Drug Profile, 2023
Author: DrugPatentWatch
Publisher: DrugPatentWatch.com
ISBN: 1934899313
Category : Medical
Languages : en
Pages : 986
Book Description
Publisher: DrugPatentWatch.com
ISBN: 1934899313
Category : Medical
Languages : en
Pages : 986
Book Description
TRUVADA Drug Profile, 2023
This report focuses on TRUVADA and covers the following critical aspects of this drug:
- United States patents
- Expired United States patents
- FDA Paragraph IV patent challenges
- District Court patent litigation
- Patent Trial and Appeal Board (PTAB) patent cases
- European supplementary protection certificates (SPCs)
- Clinical trials
- Drug prices
- Annual sales revenues
- Finished product suppliers
- Raw active pharmaceutical ingredient (API) sources